SDC1 and plasma cell myeloma: Traditional methods for detecting circulating myeloma cells, such as flow cytometry and enrichment-based techniques, are limited in sensitivity and may overlook clinically significant subpopulations of circulating myeloma cells, such as CD138-low expressing cells with greater clonogenic potential.